# Pilot Trial of XFBD, a TCM, in Persons With COVID-19

> **NCT04810689** · PHASE2 · TERMINATED · sponsor: **Darcy Spicer** · enrollment: 10 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Xuanfei Baidu Granules
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04810689
- **Lead sponsor:** Darcy Spicer
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-03-01
- **Primary completion:** 2022-06-20
- **Final completion:** 2022-06-20
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Futile Enrollment
- **Last updated:** 2025-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04810689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04810689, "Pilot Trial of XFBD, a TCM, in Persons With COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04810689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*